drugset / Trial / NCT00610545
Atorvastatin in Perioperative Vascular Surgery - Pilot Study
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular outcomes ( mortality - myocardial infarction - stroke ) when given in high doses in comparative standard doses in the perioperative period of major vascular surgery. Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization of lower limbs
Timeline
- Start
- 2007-07
- Primary completion
- 2008-09
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 20 mg | — |
| Comparator | Atorvastatin | Small molecule | 80 mg | — |
Indications
No indication recorded.